中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

2020 Vol. 36, No. 7

Display Method:
Editorial
Current status of research on inflammatory bowel disease with special comorbidities
Yang Hong, Qian JiaMing
2020, 36(7): 1441-1443. DOI: 10.3969/j.issn.1001-5256.2020.07.001
Abstract:

Inflammatory bowel disease(IBD) not only involves the intestinal tract,but also has several comorbidities outside the intestinal tract,among which there are various types of special comorbidities,including hematological system diseases,immune system diseases,and nervous system diseases. IBD with special comorbidities brings difficulties to the diagnosis and treatment of IBD,increases the disability rate and mortality rate of IBD patients,and greatly affects patients' quality of life. This article elaborates on the definition,prevalence trend,pathogenesis,and diagnosis and treatment strategies for IBD with special comorbidities,in order to improve the understanding of the importance of multidisciplinary cooperation in the diagnosis and treatment of IBD among clinicians.

Discussions by experts
Association between inflammatory bowel disease and chronic liver diseases and related management strategies
Wang JiangBin
2020, 36(7): 1444-1449. DOI: 10.3969/j.issn.1001-5256.2020.07.002
Abstract:

Inflammatory bowel disease(IBD) is often accompanied by chronic liver diseases in a variety of situations. Due to the overlapping factors in the pathogenesis of IBD and autoimmune liver diseases including primary sclerosing cholangitis( PSC),primary biliary cholangitis,and autoimmune hepatitis,the co-existence of these diseases is not uncommon,among which PSC with IBD has the highest probability of more than 80%. The probability of IBD with chronic hepatitis B virus(HBV)/hepatitis C virus(HCV) infection is associated with local infection rate,and if the screening for HBV/HCV infection is ignored before the application of immunosuppressive agents,there may be a risk of aggravated HBV/HCV infection or HBV reactivation. Long-term treatment with antibiotics,steroids,and immunosuppressants may cause drug-induced liver injury in patients with IBD. Although IBD patients often have weight loss due to the factors including diarrhea and absorption disorders,these patients may have a higher probability of nonalcoholic fatty liver disease than the general population.

Diagnosis and treatment strategies for inflammatory bowel disease with concomitant biliary diseases
Liu Yun, Liu YuLan
2020, 36(7): 1450-1453. DOI: 10.3969/j.issn.1001-5256.2020.07.003
Abstract:

Inflammatory bowel disease( IBD) is a series of non-specific chronic inflammatory diseases,including ulcerative colitis and Crohn's disease. Besides gastrointestinal symptoms,IBD patients often have extraintestinal symptoms which may involve various systems such as the skeleton and muscle,skin,eyes,liver and gallbladder,pancreas,nerves,urogenital system,lungs,heart,and blood. Biliary diseases are extraintestinal manifestations of IBD and mainly include primary sclerosing cholangitis,IgG4-associated sclerosing cholangitis,primary biliary cirrhosis,and cholelithiasis. Biliary diseases may manifest as transient abnormal liver function in asymptomatic patients and even life-threatening liver failure,and different biliary diseases may have different treatment methods and prognoses and thus require careful differential diagnosis. This article reviews biliary diseases in IBD patients,in order to help clinicians get familiar with the clinical manifestations and diagnosis and treatment strategies for biliary diseases in IBD patients.

Diagnosis and treatment strategies for pancreatic diseases in patients with inflammatory bowel disease
Guo XiaoZhong
2020, 36(7): 1454-1460. DOI: 10.3969/j.issn.1001-5256.2020.07.004
Abstract:

Inflammatory bowel disease( IBD) is a multisystem disease,and pancreatic diseases in patients with IBD should be taken seriously in clinical practice. This article systematically elaborates on the research status of acute pancreatitis,chronic pancreatitis,autoimmune pancreatitis,pancreatic exocrine dysfunction,pancreatic cancer,and asymptomatic laboratory examination and imaging abnormalities in IBD patients and analyzes the diagnosis and treatment strategies for these diseases,so as to provide an important reference for clinical identification and treatment of such diseases.

Epidemiological features of inflammatory bowel disease with hepatobiliary and pancreatic diseases
Li Jing, Wang YuFang
2020, 36(7): 1461-1466. DOI: 10.3969/j.issn.1001-5256.2020.07.005
Abstract:

Hepatobiliary and pancreatic diseases are common comorbidities of inflammatory bowel disease( IBD),and the presence of such diseases may affect the diagnosis,treatment,and prognosis of IBD and has certain value in identifying the cause of IBD. This article elaborates on the epidemiology of IBD with hepatobiliary and pancreatic diseases,so as to provide new insights for understanding the pathogenesis of IBD and formulating effective clinical treatment regimens.

Molecular mechanisms of hepatobiliary and pancreatic diseases in patients with inflammatory bowel disease
Gao Xiang, Liu ZhanJu
2020, 36(7): 1467-1473. DOI: 10.3969/j.issn.1001-5256.2020.07.006
Abstract:

Inflammatory bowel disease( IBD) is a non-specific chronic intestinal inflammatory disease with unknown etiology and pathogenesis and is often accompanied by extraintestinal manifestations involving multiple organs including the liver,the gallbladder,and the pancreas,with an important impact on the prognosis of IBD. Hepatobiliary and pancreatic complications mainly include primary sclerosing cholangitis,primary biliary cholangitis,autoimmune hepatitis,IgG4-associated sclerosing cholangitis,acute pancreatitis,chronic pancreatitis,autoimmune pancreatitis,and nonspecific increase in pancreatic enzyme. IBD-related hepatobiliary and pancreatic complications are caused by the combination of environmental and immune-mediated factors in individuals with genetic susceptibility,and this article summarizes the current research advances in the pathogenesis of such hepatobiliary inflammatory bowel disease; liver diseases; biliary tract diseases;pancreatic diseases; and pancreatic complications.

Guidelines
2020 clinical guidelines on prevention of mother-to-child transmission of hepatitis B virus
Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Chinese Society of Perinatal Medicine, Chinese Medical Association
2020, 36(7): 1474-1481. DOI: 10.3760/cma.j.cn112141-20200213-00101
Abstract:

Mother-to-child transmission( MTCT) of hepatitis B virus( HBV) is the main cause of chronic hepatitis B( CHB) in China,and the prevention of MTCT plays a critical role in controlling CHB. Based on Clinical guidelines for the prevention of mother-to-child transmission of hepatitis B virus( First Edition) issued in 2013,the current clinical guidelines have updated the recommendations,mainly including:( 1) all pregnant women should undergo the prenatal screening for hepatitis B serological markers;( 2) neonates whose mothers have negative HBsAg should receive hepatitis B vaccination according to the regimen of “0,1,and 6 months”,and there is generally no need for hepatitis B immunoglobulin( HBIG);( 3) neonates whose mothers have positive HBsAg need intramuscular injection of HBIG at one dose and the first dose of hepatitis B vaccine within 12 hours after birth( the sooner the better),followed by injection of the second and third doses of hepatitis B vaccine at the age of 1 and 6 months,respectively;( 4) to further reduce MTCT of HBV,pregnant women with HBV DNA > 2 × 105 IU/ml or with positive HBe Ag may start to take oral antivirals at the 28-32 weeks of gestation until the day of delivery;( 5) cesarean section,with the purpose to reduce MTCT of HBV,is not recommended.

Consensus for clinical application of molecular diagnosis on hepatobiliary carcinoma
Society for Hepatobiliary, Medical Society of Western Retuned Scholars Association, Society for Molecular Diagnosis, Chinese Research Hospital Association, SMD/CRHA, Expert Committee for Liver Cancer, Chinese Society of Clinical oncology, Professional Committee for the Prevention and Control of Hepatobiliary and Pancreatic Diseases, Chinese Preventive Medicine Association, Expert Committee for Liver Cancer, Asia Pacific Alliance of Liver Diseases
2020, 36(7): 1482-1488. DOI: 10.3969/j.issn.1001-5256.2020.07.008
Abstract:

In hepatobiliary carcinoma,serologic and histologic biomarkers including proteins and genes have been recommended and categorized for cancer diagnosis,targeted therapy and immunotherapy regimen selection,as well as prognostic prediction at different levels. To standardize the application of molecular biomarkers in clinical diagnosis,therapeutic evaluation,and prognosis prediction of primary hepatobiliary carcinoma,the specialist committee has summarized the current well studies biomarkers with clinical significance in both serum and tumor tissue as well as provided professional agreements on their potential utilization in this consensus. Moreover,we have made recommendations on standards for laboratory detection,technical operation,data analysis,result interpretation,clinical report,and the whole-process quality management in serological,histopathological detection and next-generation sequencing. According to these,the committee aims to offer clinical staffs with scientific and practical references and guidance to achieve better personalized treatment decisions from these up-to-date knowledges of molecular diagnosis on hepatobiliary carcinoma.

An excerpt of important unresolved questions in the management of hepatic encephalopathy: An ISHEN consensus
Liang Jing, Han Tao
2020, 36(7): 1489-1490. DOI: 10.3969/j.issn.1001-5256.2020.07.009
Abstract:
Original articles_Viral hepatitis
Influence of long-term entecavir treatment on renal function in patients with chronic hepatitis B
Zhang Qing, Zhang Biao, Wang Pei, Li Ying, Yan XueBing, Ding Qin
2020, 36(7): 1491-1495. DOI: 10.3969/j.issn.1001-5256.2020.07.010
Abstract:
Objective To investigate the influence of long-term entecavir( ETV) antiviral therapy on renal function in patients with chronic hepatitis B( CHB). Methods A retrospective analysis was performed for the clinical data of 232 CHB patients who received ETV antiviral therapy for more than half a year in Huai'an Fourth People's Hospital from January 2015 to June 2019. The patients were divided into groups according to sex,age( < 65 years or ≥65 years),presence or absence of liver cirrhosis,and estimated glomerular filtration rate( eGFR)( < 90 ml/min/1. 73 m2 or ≥90 ml/min/1. 73 m2),and the changes in renal function markers[blood urea nitrogen( BUN),serum creatinine( SCr),and eGFR] after treatment were observed for each group. The changes in alanine aminotransferase( ALT),aspartate aminotransferase( AST),albumin( Alb),HBsAg,HBV DNA,and renal function markers( BUN,SCr,and eGFR) after ETV antiviral therapy were also observed. An automatic biochemical analyzer was used to measure biochemical parameters including ALT,AST,Alb,BUN,SCr,and eGFR; RT-qPCR was used to measure HBV DNA; Roche electrochemical luminescence was used to measure serum HBsAg quantification. The paired t-test was used for comparison of normally distributed continuous data between groups,and the Wilcoxon rank-sum test was used for comparison of non-normally distributed continuous data between groups; a binary logistic regression analysis was used to identify the risk factors for eGFR < 90 ml/min/1. 73 m2 after ETV antiviral therapy. Results After ETV antiviral therapy for more than half a year,there were significant reductions in ALT,AST,HBs Ag,and HBV DNA( Z =-9. 496 and-9. 577,t = 5. 013 and20. 777,all P < 0. 05) and a significant increase in Alb( t =-10. 832,P < 0. 05); compared with baseline,there were significant increases in BUN and SCr( t =-2. 685 and-2. 376,both P < 0. 05) and a significant reduction in e GFR( t = 3. 207,P < 0. 05). Further analysis of each subgroup showed that the e GFR ≥90 ml/min/1. 73 m2 group,the non-elderly group,the liver cirrhosis group,and the male group had significant increases in BUN( t =-3. 403,-3. 187,-2. 267,and-2. 187,all P < 0. 05) and SCr( t =-3. 716,-3. 614,-2. 291,and-2. 115,all P < 0. 05) and a significant reduction in e GFR( t = 4. 846,4. 152,2. 458,and 2. 946,all P < 0. 05),and the non-liver cirrhosis group had a significant reduction in e GFR( t = 2. 163,P < 0. 05) and had no significant changes in BUN and SCr( P >0. 05). The binary logistic regression analysis showed that with the increase in glucose level( odds ratio [OR]= 1. 296,95% confidence interval [Cl]: 1. 052-1. 597,P = 0. 015) and the reduction in total cholesterol( TC)( OR = 0. 436,95% Cl: 0. 286-0. 664,P <0. 001),the risk of e GFR < 90 ml/min/1. 73 m2 increased after ETV therapy. Conclusion ETV antiviral therapy can effectively reduce ALT,AST,HBs Ag,and HBV DNA and increase Alb,but it can cause the increases in BUN and SCr and the reduction in e GFR in patients with e GFR > 90 ml/min/1. 73 m2,non-elderly patients,and patients with liver cirrhosis. Blood glucose and TC are influencing factors for eGFR < 90 ml/min/1. 73 m2 after ETV therapy.
Changes in senescence-and function-related parameters of CD8+T cells after direct-acting antiviral treatment in patients with hepatitis C virus infection
Zhang PeiXin, Bian PeiYu, Ye ChuanTao, Zheng XuYang, Fan Chao, Zhang Ying, Jia ZhanSheng, Zhou Yun
2020, 36(7): 1496-1501. DOI: 10.3969/j.issn.1001-5256.2020.07.011
Abstract:

Objective To investigate the changes in the senescence-and function-related parameters of CD8+T cells after direct-acting antiviral( DAA) treatment and their clinical significance in patients with hepatitis C virus( HCV) infection. Methods A total of 26 patients with HCV infection who attended the Second Affiliated Hospital of Air Force Medical University from January 2017 to December 2018 were enrolled,and all patients were given sofosbuvir and daclatasvir tablets. A total of 22 patients who were cured and 20 healthy controls were enrolled. Flow cytometry was used to measure the expression of silent information regulator 1( SIRT1),CD57,programmed death-1( PD-1),and Tim-3 on CD8+T cells; RT-PCR was used to measure the expression of p21 and p53; Luminex liquid suspension chip was used to observe senescence-associated secretory phenotype in peripheral blood. A one-way analysis of variance was used for comparison of continuous data between multiple groups,and the least significant difference t-test was used for further comparison between two groups. Results There were significant differences in the expression of SIRT1,PD-1,and Tim-3 between the three groups( F = 6. 712,4. 202,and 4. 575,all P < 0. 05). Compared with the healthy control group,the HCV group had significant increases in the expression of SIRT1,PD-1,and Tim-3 on CD8+T cells( all P < 0. 05),and the HCV cured group had a significant increase in the expression of Tim-3( P< 0. 05),with no significant changes in SIRT1 and PD-1( both P > 0. 05). There were significant differences in the expression of p53 and p21 between the three groups( F = 11. 144 and 6. 594,both P < 0. 05). Compared with the healthy control group,the HCV cured group and the HCV group had significant reductions in the expression of p53( both P < 0. 001) and p21( both P < 0. 05),and there were no significant differences between the HCV group and the HCV cured group( both P > 0. 05). There were significant differences in interleukin-6 ( IL-6) and tumor necrosis factor α( TNFα) between the three groups( F = 3. 920 and 6. 337,both P < 0. 05),and compared with the healthy control group,the HCV group had significant increases in the levels of IL-6 and TNFα in peripheral blood( both P < 0. 05). There were no significant changes in IL-6 and TNFα in the HCV cured group( both P > 0. 05),and compared with the HCV group,the HCV cured group had a significant reduction in the level of TNFα( P = 0. 007). Conclusion Senescence of CD8+T cells is observed in patients with HCV infection and is alleviated after DAA treatment,with partial recovery of the function of CD8+T cells.

Original articles_Liver fibrosis and liver cirrhosis
Clinical effect of Huanglian Wendan decoction in treatment of chronic hepatitis B liver fibrosis patients with liver-gallbladder damp-heat syndrome
Xie AiZe, Mao DeWen, Shi QingLan, Lu: Chao, Bo WenJie
2020, 36(7): 1502-1507. DOI: 10.3969/j.issn.1001-5256.2020.07.012
Abstract:
Objective To investigate the clinical effect of Huanglian Wendan decoction in the treatment of chronic hepatitis B liver fibrosis patients with liver-gallbladder damp-heat syndrome and its regulatory effect on T helper 17( Th17) cells/interleukin-17( IL-17) inflammatory axis. Methods A total of 128 chronic hepatitis B liver fibrosis patients with liver-gallbladder damp-heat syndrome who were diagnosed and treated in The First Affiliated Hospital of Guangxi University of Chinese Medicine from January 2016 to December 2018 were enrolled and divided into treatment group and control group using a random number table,with 64 patients in each group. In addition to the treatment with the nucleoside drug entecavir dispersible tablets,the patients in the control group were given the traditional Chinese medicine( TCM) placebo,and those in the treatment group were given oral administration of Huanglian Wendan decoction. The course of treatment was 24 weeks for both groups. The two groups were compared in terms of symptom score of liver-gallbladder damp-heat syndrome,liver function,serological parameters for liver fibrosis,liver stiffness measurement( LSM),and levels of IL-17 and Th17 cells in peripheral blood. The t-test was used for comparison of continuous data between two groups; a one-way analysis of variance was used for comparison within each group at different time points,and the least significant difference t-test was used for further comparison between two time points. The chi-square test was used for comparison of categorical data between two groups. Results After 12 and 24 weeks of treatment,both groups had significant reductions in the scores of the symptoms of liver-gallbladder damp-heat syndrome( distending pain in the hypochondrium,jaundice of the skin and eyes,deep-colored urine,dry mouth and bitter taste,and slimy yellow tongue fur)( all P < 0. 01),and there were significant differences in the scores of the symptoms of liver-gallbladder damp-heat syndrome between the two groups( all P < 0. 01). After 12 and 24 weeks of treatment,both groups had significant reductions in the liver function parameters aspartate aminotransferase,alanine aminotransferase,total bilirubin,and gamma-glutamyl transpeptidase( all P < 0. 01),and there were significant differences in these liver function parameters between the two groups( all P < 0. 01). After 12 and 24 weeks of treatment,both groups had significant reductions in serological parameters for liver fibrosis( hyaluronic acid,procollagen type Ⅲ,type Ⅳ collagen,and laminin) and LSM( all P < 0. 01),and there were significant differences in these serological parameters for liver fibrosis and LSM between the two groups( both P < 0. 01). After 24 weeks of treatment,the treatment group had significant reductions in the count of Th17 cells and the level of IL-17 in peripheral blood( t = 2. 79 and 2. 60,both P < 0. 01),and the control group had a significant reduction in the count of Th17 cells in peripheral blood( t = 2. 47,P < 0. 01); after 24 weeks of treatment,the treatment grop had significantly lower count of Th17 cells and level of IL-17 in peripheral blood than the control group( both P < 0. 01). There was a significant difference in overall response rate between the control group and the treatment group( 76. 56% vs 90. 63%,χ2= 4. 61,P < 0. 05). Conclusion On the basis of antiviral therapy with nucleosides in Western medicine,Huanglian Wendan decoction has a marked clinical effect in the treatment of chronic hepatitis B liver fibrosis patients with liver-gallbladder damp-heat syndrome,possibly by regulating the Th17/IL-17 inflammatory axis.
Molecular mechanism of the anti-liver fibrosis effect of curcumol: An analysis based on the TLR4/NF-κB signaling pathway
Zheng Yang, Wang JiaRu, Liu LuLu, Wang JiaHui, Zhao TieJian
2020, 36(7): 1508-1513. DOI: 10.3969/j.issn.1001-5256.2020.07.013
Abstract:

Objective To investigate the molecular mechanism of the anti-liver fibrosis effect of curcumol by observing the effect of curcumol on the TLR4/NF-κB signaling pathway in liver sinusoidal endothelial cells. Methods A total of 50 mice were randomly divided into blank group,model group,and curcumol group,and cells were divided into blank control group,LPS positive control group,curcumol intervention group,and PDTC group. HE staining and Masson staining were used to observe the change in liver structure; Western blot and quantitative real-time PCR( RT-PCR) were used to measure the protein and mRNA expression of the key molecules TLR4 and NF-κB in the TLR4/NF-κB signaling pathway; immunofluorescence assay was used to observe the expression and nuclear import of NF-κB in cells. A one-way analysis of variance was used for comparison between multiple groups,and the least significant difference t-test was used for further comparison between two groups. Results RT-PCR showed that compared with the positive control group,the curcumol intervention group had significant reductions in the mRNA expression of TLR4 and NF-κB( both P < 0. 05). Western blot showed that compared with the positive control group,the curcumol intervention group had significant reductions in the expression of TLR4 and NF-κB( both P <0. 05). Immunofluorescence assay showed that compared with the positive control group,the curcumol intervention group had significant improvement in NF-κB nuclear import. Conclusion Curcumol can exert an anti-liver fibrosis effect possibly by inhibiting the activity of the TLR4/NF-κB signaling pathway.

Molecular mechanism of elastin and its regulatory factors on the formation and reversal of liver fibrosis in a mouse model of liver fibrosis
Yang AiTing, Yan XuZhen, Zhao WenShan, Li WeiYu, Chen Wei, You Hong
2020, 36(7): 1514-1519. DOI: 10.3969/j.issn.1001-5256.2020.07.014
Abstract:

Objective To investigate the expression of elastin in a mouse model of carbon tetrachloride( CCl4)-induced liver fibrosis and the molecular mechanism of elastin deposition. Methods A mouse model of CCl4-induced liver fibrosis was established. Western blot,soluble protein,and Victoria blue staining were used to measure the change in elastin in the early stage of liver fibrosis( after 4 weeks of CCl4 injection) and the progressive stage of liver fibrosis( after 8 weeks of CCl4 injection). The mice treated with olive oil were enrolled as healthy control group. A model of spontaneous reversal of fibrosis was established; liquid chromatography-tandem mass spectrometry( LC-MS/MS) was used to measure the change in serum proteomics at different time points of reversal( at weeks 0,4,8,and 12 of reversal) and identify the potential molecules associated with elastin deposition,and qPCR was used for validation. A one-way analysis of variance was used for comparison of continuous data between multiple groups,and the least signficant difference Tukey test was used for further comparison between two groups. Results The relative expression of elastin was 0. 82 ± 0. 05 in the early fibrosis group and 1. 59 ± 0. 58 in the progressive fibrosis group,and compared with the healthy control group,the progressive fibrosis group had a significant increase in the expression of elastin( 1. 59 ± 0. 58 vs 1. 00 ± 0. 11,P < 0. 05). The measurement of insoluble elastin showed that compared with the healthy control group( 207. 9 ± 34. 7 μg/10 mg),the early fibrosis group had no significant change in insoluble elastin( 213. 5 ± 26. 7 μg/10 mg,P >0. 05),and the progressive fibrosis group had a significant increase in insoluble elastin( 352. 0 ± 57. 0 μg/10 mg,P < 0. 05). Elastin staining of liver tissue showed that compared with the healthy control group,the early fibrosis group and the progressive fibrosis group had a significant increase in the area of liver tissue with positive elastin expression( 2. 08 ± 0. 16/4. 39 ± 0. 51 vs 1. 03 ± 0. 14,both P < 0. 05). The mRNA expression of elastase 12 was measured,and the results showed that compared with the healthy control group,the early fibrosis group and the progressive fibrosis group had a significant increase in the mRNA expression of elastase 12( 15. 50 ± 2. 90/22. 70 ± 4. 10 vs 1. 30 ±0. 10,both P < 0. 05),suggesting that the mRNA expression of elastase 12 increased with the progression of liver fibrosis. During the reversal of liver fibrosis,45 proteins associated with the progression and reversal of liver fibrosis were isolated and identified by LC-MS/MS,among which lysyl oxidase-like protein-1( LOXL-1) and fibulin-1( FBLN-1) were associated with elastin deposition. Validation of LOXL-1 and FBLN-1 by q PCR showed that the mRNA expression of LOXL-1 and FBLN-1 reached the peak after 8 weeks of CCl4 injection( week 0 of reversal) and then gradually decreased over the time of reversal. Conclusion Elastin deposition is one of the important features in a mouse model of progressive liver fibrosis,and elastin deposition mediated by LOXL-1 and FBLN-1 may become a treatment target for liver fibrosis,liver cirrhosis,and end-stage liver disease.

A comparative study of intestinal flora between hepatitis B cirrhosis patients with or without ascites
Luan YuTing, Cai WenJun, Jiang ShiLi, Zhao ZhangQing, Gu HongTu, Yuan JiLi, Xing Feng, Lu: Jing, Liu ChengHai, Liu Ping, Mu YongPing
2020, 36(7): 1520-1526. DOI: 10.3969/j.issn.1001-5256.2020.07.015
Abstract:
Objective To investigate the difference in intestinal flora between hepatitis B liver cirrhosis( HBLC) patients with or without ascites. Methods A total of 57 patients with HBLC who visited Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from October to December 2016 were enrolled,among whom 30 had no ascites( HBLC-WOA group) and 27 had ascites without spontaneous peritonitis( SBP)( HBLC-WA group),and 28 healthy volunteers were enrolled as healthy controls( HC group). Intestinal flora was compared between the two groups of HBLC patients using 16 S rRNA sequencing. The Wilcoxon rank sum test was used for comparison of categorical data between two groups,and the Mann-Whitney U test was used for comparison of continuous data between two groups;the Kruskal-Wallis H test was used for comparison of continuous variables between more than two groups. Multiple hypothesis tests were used for comparison of relative abundance between species and was adjusted by Benjamini and Hochberg false discovery rate( fdr),and Pfdr< 0. 05 was considered statistically significant. The Spearman rank correlation test was used for correlation analysis. An analysis of similarity( ANOSIM) and a non-parametric multivariate analysis of variance( Adonis) were used for comparison between groups under different conditions. Results The abundance of fecal microbiota gradually decreased with the appearance of ascites in HBLC patients( P = 0. 042).There were significant differences between the HBLC-WOA group and the HC group( ANOSIM: R = 0. 159,P = 0. 001; Adonis: R2=0. 067,P = 0. 001) and between the HBLC-WA group and the HC group( ANOSIM: R = 0. 323,P = 0. 001; Adonis: R2= 0. 107,P =0. 001). At the genus level,compared with the HC group,the HBLC-WA group had significant reductions in the abundance of Subdoligranulum and Pseudobutyrivibrio( P < 0. 01 and P < 0. 001) and significant increases in the abundance of Enterobacter,Escherichia,and Veillonella( P < 0. 05,P < 0. 001,and P < 0. 01). Escherichia and Veillonella were positively correlated with Child-Turcotte-Pugh( CTP) score,prothrombin time,and international normalized ratio and were negatively correlated with serum albumin( Alb) level( all P <0. 05). Pseudobutyrivibrio,norank _f _ Lachnospiraceae,unclassified _ f _ Lachnospiraceae,and Blautia were positively correlated with Alb level and were negatively correlated with CTP score and C-reactive protein level( all P < 0. 05). The KEGG pathway analysis showed that with the appearance of ascites,there were gradual increases in the abundance of the pathways associated with transcription-related proteins,alpha-linolenic acid metabolism,Staphylococcus aureus infection,bacterial invasion of epithelial cells,and bile secretion( all Pfdr< 0. 05),as well as a gradual reduction in the abundance of the pathway associated with the biosynthesis of flavonoids( Pfdr< 0. 05). The pathway associated with bacterial invasion of epithelial cells was positively correlated with the abundance of Escherichia( P < 0. 001),and the abundance of Enterobacter was positively correlated with the pathway of bile secretion( P < 0. 001). Conclusion Intestinal flora disturbance is observed in HBLC-WA patients,featuring the reductions in the abundance of Subdoligranulum and Pseudobutyrivibrio belonging to Firmicutes and the increases in the abundance of Enterobacter and Escherichia belonging to Proteobacteria. Enterobacter may be involved in the pathway of bile secretion,and Escherichia may be involved in the pathway associated with bacterial invasion of epithelial cells. It is suggested that regulation of intestinal flora,as well as the prophylactic treatment of SBP,should be considered for HBLC-WA patients without SBP.
Features of intestinal flora imbalance in patients with liver cirrhosis and related driving factors
Guo XiaoXia, Hu Na, Lian XiaoXiao, Sun YuanPei, Li YuZhen, Lu: Lei, Ye YongAn, Li XiaoKe
2020, 36(7): 1527-1533. DOI: 10.3969/j.issn.1001-5256.2020.07.016
Abstract:

Objective To investigate the distribution characteristics of intestinal flora in patients with liver cirrhosis,the driving factors for intestinal flora variation,and their association with the severity of liver cirrhosis. Methods Blood and stool specimens were collected from10 healthy volunteers and 70 patients with liver cirrhosis who were recruited by Shanxi Provincial Hospital of Traditional Chinese Medicine from August 2017 to August 2019. High-throughput sequencing of bacterial 16 S rDNA was performed to identify differentially expressed bacterial genera in intestinal flora of patients with liver cirrhosis. A one-way analysis of variance was used for comparison of normally distributed continuous data between groups,and the Kruskal-Wallis H test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups. A Spearman correlation analysis was performed,and CANOCO5. 0 software was used to perform RDA analysis to investigate the association of clinical indices with intestinal flora variation. Results Specific changes were observed in the species of intestinal flora in patients with liver cirrhosis,and compared with the healthy control group,the patients with liver cirrhosis had 81 unique operational taxonomic units( OTUs) in the metagenome of intestinal flora,among which there were 39 albumin-bilirubin( ALBI) grade 1 OTUs,34 ALBI grade 2 OTUs,and 8 ALBI grade 3 OTUs. With the progression of liver cirrhosis,there were significant reductions in Chao1 index and ACE index( H = 8. 111 and 9. 112,P = 0. 044 and0. 028),which were significantly negatively correlated with ALBI grade( r =-0. 287 and-0. 297,P = 0. 016 and 0. 012). Compared with the healthy control group,the patients with liver cirrhosis had significant increases in four genera of pathogenic bacteria( Roseburia,Veillonella,Streptococcus,and Haemophilus) and significant reductions in two genera of probiotic bacteria( Coprococcus and Clostridium)as the main features of intestinal flora imbalance( H = 15. 96,13. 01,8. 94,11. 09,13. 07,and 16. 27,all P < 0. 05). There was a positive correlation between the two genera of probiotic bacteria( P < 0. 05) and the four genera of pathogenic bacteria( P < 0. 001),while Coprococcus of probiotic bacteria was negatively correlated with the four genera of pathogenic bacteria( P < 0. 001). The correlation analysis of the differentially expressed genera and clinical indices showed that Coprococcus of probiotic bacteria was positively correlated with albumin( Alb)( r = 0. 273,P = 0. 022) and negatively correlated with prothrombin time( PT) and ALBI score( r =-0. 300 and-0. 263,both P < 0. 05); the pathogenic bacteria Rossella,Veillonella,Streptococcus,and Haemophilus were negatively correlated with Alb and positively correlated with PT,total bilirubin( TBil),ALBI score( all P < 0. 05). The RDA analysis showed that PT,TBil,and aspartate aminotransferase were highly correlated with the distribution of intestinal flora,among which PT had the most significant effect on intestinal flora variation( P = 0. 002). In the healthy control group,ALBI grade 1/2/3 OTUs had a cirrhosis dysbiosis index of genus( CDIG) of 2. 58,0. 76,0. 24,and 0. 04,respectively( H = 16. 750,P < 0. 001),and CDIG was negatively correlated with TBil,PT,and ALBI( r =-0. 313,-0. 323,and-0. 366,P = 0. 008,0. 006,and 0. 002). Conclusion Excessive growth of pathogenic bacteria,a lack of probiotic bacteria,and the ratio imbalance between various bacterial genera are the main characteristics of intestinal flora imbalance in patients with liver cirrhosis,and PT is the main driving factor for intestinal flora variation. CDIG can reflect the degree of intestinal flora imbalance in patients with liver cirrhosis,and the severity of liver cirrhosis increases with the reduction in CDIG.

Original articles_Liver neoplasms
Influence of 5-hydroxytryptamine and platelet count in peripheral blood on the prognosis of patients with hepatocellular carcinoma
Wang ZhiXin, Li Yao, Zhou LiuXin, Ren Li, Qu Kai, Miao Run, Hou LiChao, Wang HaiJiu, Liu Chang, Fan HaiNing
2020, 36(7): 1534-1539. DOI: 10.3969/j.issn.1001-5256.2020.07.017
Abstract:

Objective To investigate the association of platelet and its endogenous 5-hydroxytryptamine( 5-HT) with the prognosis of patients with hepatocellular carcinoma( HCC). Methods A retrospective analysis was performed for the clinical data of 210 patients with HCC who were treated in The First Affiliated Hospital of Xi'an Jiaotong University from January 2004 to December 2012,and according to platelet count,the patients were divided into low platelet group and high platelet group. Related factors and prognosis were compared between two groups. Peripheral blood samples were collected from 20 patients with recurrent/metastatic liver cancer and 32 patients with non-recurrent/metastatic liver cancer; ELISA was used to measure the serum level of 5-HT,and the platelet aggregation instrument was used to measure platelet aggregation rate. The chi-square test was used to investigate the association between platelet count and the clinicopathological characteristics of liver cancer,and the Mann-Whitney U test was used to compare platelet count,platelet aggregation rate,and 5-HT level in peripheral blood between groups. A univariate linear regression analysis was used to investigate the association between platelet count and survival time,as well as the association of 5-HT level with platelet count and platelet aggregation rate. The Kaplan-Meier method was used to analyze survival rate and recurrence rate,the log-rank test was used for comparison between groups,and a Cox regression analysis was used to investigate the influencing factors for the prognosis of HCC patients. Results There were significant differences between the patients with different platelet counts in age( χ2= 32. 304,P = 0. 044),tumor size( χ2= 35. 201,P = 0. 001),number of tumors( χ2=31. 304,P = 0. 032),Child class( χ2= 31. 250,P = 0. 036),and TNM stage( χ2= 35. 201,P = 0. 001). The multivariate Cox regression analysis showed that age,alpha-fetoprotein( AFP) level on admission,platelet count on admission,and treatment modality were independent risk factors associated with overall survival( all P < 0. 05),while age,AFP level on admission,tumor size,platelet count on admission,and treatment modality were risk factors associated with recurrence-free survival( all P < 0. 05). The survival analysis showed that compared with the low platelet group,the high platelet group had a significantly lower overall survival rate( χ2= 34. 060,P < 0. 001) and a significantly higher recurrence rate( χ2= 31. 030,P < 0. 001). With the increase in platelet count,overall survival and recurrence-free survival tended to decrease( R2 OS= 0. 034,POS= 0. 007; R2 DFS= 0. 045,PDFS= 0. 002). Compared with the non-recurrent/metastatic liver cancer group,the recurrent/metastatic liver cancer group had significantly higher platelet count( U = 2. 950,P = 0. 041),platelet aggregation rate( U = 2. 363,P = 0. 043),and serum free 5-HT level( U = 3. 082,P = 0. 048). The correlation analysis showed that serum 5-HT level was positively correlated with platelet count and maximum platelet aggregation rate in peripheral blood( both P < 0. 05). Conclusion Platelet count is an independent risk factor for overall survival and recurrence/metastasis in patients with HCC. Peripheral 5-HT level is positively correlated with platelet count and platelet aggregation rate and may be one of the potential indices for predicting the prognosis of HCC patients.

Association of TLR4 gene polymorphism with susceptibility to and prognosis of hepatitis B virus-related primary liver cancer
He WeiLi, Yang XiaoYue, Zhang AiJun, Wang XiaoYang, Wang YaJun, Zhao Fan, Xu GuangFu
2020, 36(7): 1540-1544. DOI: 10.3969/j.issn.1001-5256.2020.07.018
Abstract:

Objective To investigate the association of TLR4 gene polymorphism with the susceptibility to hepatitis B virus( HBV)-related primary liver cancer and its influence on the prognosis of patients. Methods A total of 106 patients with HBV-related liver cancer who were admitted to Beijing YouAn Hospital which cooperated with Dongzhimen Hospital of Beijing University of Chinese Medicine from June2015 to July 2017 were enrolled as liver cancer group; 120 patients with chronic hepatitis B who were admitted during the same period of time in Dongzhimen Hospital of Beijing University of Chinese Medicine were enrolled as hepatitis B group,and 100 healthy control subjects were enrolled as control group. Blood samples were collected from each group to detect TLR4 D299 G,T399 I,and A896 G polymorphisms,and postoperative recurrence was analyzed for liver cancer patients with different genotypes. An analysis of variance was used for comparison of continuous data between multiple groups,and the least significant difference t-test was used for further comparison between two groups;the chi-square test was used for comparison of categorical data between two groups,and the Kruskal-Wallis H test was used for comparison between multiple groups. An unconditional logistic regression model and odds ratio( OR) used to estimate relative risk were used to investigate the association of each factor with the onset risk of HBV-related primary liver cancer; the Kaplan-Meier curves were plotted for survival analysis,and the log-rank test was used for comparison of survival curves between groups. Results There were no significant differences in the genotype and allele distributions of TLR4 D299 G and TLR4 A896 G between the three groups( χ2= 1. 436,1. 949,1. 851,and2. 599,all P > 0. 05),while there were significant differences in the genotype and allele distributions of TLR4 T399 I between the three groups( χ2= 11. 654 and 14. 995,both P < 0. 05),and the liver cancer group had a significantly higher frequency of T allele than the hepatitis B group and the control group( P < 0. 05). The unconditional logistic regression model showed that CC genotype of TLR4 T399 I had an OR of 1. 682( 95% confidence interval[CI]: 1. 109-2. 243,P = 0. 027),TT genotype of TLR4 T399 I had an OR of 2. 103( 95% CI:1. 347-2. 896,P < 0. 001),and T allele of TLR4 T399 I had an OR of 1. 872( 95% CI: 1. 192-2. 374,P = 0. 002). There was no significant difference in recurrence-free survival after surgery between the liver cancer patients with different genotypes of TLR4 D299 G and TLR4 A896 G( χ2= 0. 022 and 0. 471,both P > 0. 05). The liver cancer patients with CC genotype of TLR4 T399 I had significantly better recurrence-free survival after surgery than those with CT or TT genotype( χ2= 6. 781,P < 0. 05). Conclusion TLR4 T399 I gene polymorphism is closely associated with the susceptibility to HBV-related primary liver cancer,and T gene of TLR4 T399 I may be an important factor for tumorigenesis and poor prognosis.

Original articles_Other liver diseases
Clinical effect of vitamin E in treatment of nonalcoholic fatty liver disease in children: A Meta-analysis
Liu ShenShen, Xing YiQing, Wang Ning, Yu QiaoLing, Ceng LePing
2020, 36(7): 1545-1550. DOI: 10.3969/j.issn.1001-5256.2020.07.019
Abstract:

Objective To investigate the clinical effect of vitamin E in the treatment of nonalcoholic fatty liver disease( NAFLD) in children. Methods PubMed,Web of Science,The Cochran Library,Embase,OVID/NEJM,CNKI,and Wanfang Data were searched for the articles on vitamin E in the treatment of NAFLD in children published up to December 2019. The data of 8 parameters were analyzed,i. e.,body mass index( BMI),liver enzymes [alanine aminotransferase( ALT) and aspartate aminotransferase( AST) ],blood lipid levels [triglyceride( TG),total cholesterol( TC),low-density lipoprotein( LDL),and high-density lipoprotein( HDL) ],and remission rate of hepatic steatosis. RevMan 5. 3 was used to perform a Meta-analysis. Continuous variables were analyzed by standardized mean difference( SMD) and 95% confidence interval( CI),and the changes after intervention were analyzed; categorical variables were analyzed by risk difference( RD) and 95% CI. A fixed effects model was used for homogeneous data,and a random effects model was used for heterogeneous data. Funnel plots were used to evaluate publication bias. Results A total of 599 articles were retrieved,among which 9 were included in the Meta-analysis,with 607 subjects in total. Vitamin E significantly improved the level of ALT( SMD =-0. 27,95% CI:-0. 48 to-0. 06,P = 0. 01),but it did not improve the levels of BMI( SMD =-0. 09,95% CI:-0. 28 to 0. 10,P = 0. 34),AST( SMD =-0. 20,95% CI:-0. 42 to 0. 02,P = 0. 07),TG( SMD =-0. 19,95% CI:-0. 51 to 0. 12,P = 0. 22),TCHO( SMD =-0. 11,95% CI:-0. 31 to 0. 08,P = 0. 24),HDL( SMD =-0. 02,95% CI:-0. 27 to 0. 23,P = 0. 88),LDL( SMD =-0. 04,95% CI:-0. 27 to0. 19,P = 0. 72),and the remission rate of hepatic steatosis( RD = 0. 06,95% CI:-0. 05 to 0. 17,P = 0. 29). Conclusion Vitamin E can significantly improve the level of ALT in children with NAFLD and can be considered as an adjuvant drug for clinical treatment.

Effect of Ganshuang granules on lipid metabolism in a new tissue-engineering model of nonalcoholic fatty liver disease
Zhang YiZhi, Duan ZhongPing, Zhang XiaoHui, Chen Yu
2020, 36(7): 1551-1555. DOI: 10.3969/j.issn.1001-5256.2020.07.020
Abstract:
Objective To investigate the effect of Ganshuang granules( GSG) intervention on lipid metabolism in a new tissue-engineering model of nonalcoholic fatty liver disease( NAFLD) and its mechanism. Methods The liver of Sprague-Dawley rats was decellularized into collagen scaffolds,and human HepG2 cells were used to recellularize the scaffolds to obtain the tissue-engineering( TE) liver as normal control group. The TE liver was perfused with high-fat medium containing free fatty acid( FFA) to establish a model of NAFLD( FFA group),and this model was further treated with GSG extract to establish a FFA + GSG group. These groups were compared in terms of the content of triglyceride( TG) and the mRNA expression of PDK4 in the liver,and the mRNA expression of enzymes associated with lipid metabolism was compared between the FFA group and the FFA + GSG group; oil red O staining was used to evaluate liver pathology. The t-test was used for comparison of continuous data between groups. Results Compared with the normal control group,the FFA group had significantly higher content of TG( t = 4. 842,P = 0. 004 7) and mRNA expression of PDK4( t = 2. 784,P = 0. 031 8). Compared with the FFA group,the FFA + GSG group had significant reductions in the content of TG in cells( t = 0. 055,P = 0. 003 7),the expression of PDK4( t = 3. 761,P = 0. 009 4),and the mRNA expression of fatty acid translocase,fatty acid-binding protein 1,ATP citrate lyase,acetyl-CoA carboxylase,fatty acid synthase,fatty acid desaturase 2,1-acylglycerol-3-phosphate O-acyltransferase 5,and apolipoprotein B( t = 6. 552,4. 944,2. 689,4. 524,6. 040,3. 758,4. 443,and 3. 032,P = 0. 007 2,0. 001 1,0. 027 6,0. 020 2,0. 009 1,0. 005 6,0. 047 1,and 0. 016 3). Oil red O staining showed significant reductions in the number of lipid droplets in hepatocytes and the degree of hepatocyte fatty degeneration. Conclusion GSG can reduce the intake of FFA,the de novo synthesis of fatty acid,and the generation and deposition of TG in hepatocytes in the model of NAFLD and thus improve dyslipidemia.
A comparative analysis of the clinical features of acute and chronic drug-induced liver injury
Ji TongTong, Lu HaiYing, Tan Ning, Yu YanYan, Xu XiaoYuan
2020, 36(7): 1556-1561. DOI: 10.3969/j.issn.1001-5256.2020.07.021
Abstract:

Objective To investigate the similarities and differences in the clinical features of acute versus chronic drug-induced liver injury( DILI). Methods Clinical data were collected from 183 patients who were hospitalized and diagnosed with DILI in Department of Infectious Diseases,Peking University First Hospital,from January 2015 to December 2018,and the patients were divided into acute group with 138 patients and chronic group with 45 patients. Related data were collected,including general information,underlying diseases,history of suspected drugs,history of allergy,drinking history,symptoms and signs,laboratory examination,radiological examination,liver biopsy,treatment,and prognosis. Roussel Uclaf Causality Assessment Method( RUCAM) score was determined for all patients diagnosed with DILI,and the type and severity of liver injury were determined. The t-test was used for comparison of normally distributed continuous data between groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups; a logistic regression analysis was used to investigate the influencing factors for chronicity of DILI. Results Among the 138 patients in the acute group,105( 76. 1%) had DILI caused by Chinese herbal medicine and 15( 10. 9%) had DILI caused by antibiotics,while among the 45 patients in the chronic group,33( 73. 3%) had DILI caused by Chinese herbal medicine and 5( 11. 1%) had DILI caused by antibiotics. There were significant differences between the two groups in sex( χ2= 4. 774,P = 0. 029),type of liver injury( χ2= 9. 848,P = 0. 02),and severity of DILI( χ2= 8. 012,P = 0. 046);77. 8% of the patients in the chronic group had a RUCAM score of ≤6,while 79. 7% of the patients in the acute group had a RUCAM score of ≥6,and there was a significant difference between the two groups( χ2= 21. 471,P = 0. 002). There were significant differences between the two groups in platelet count( PLT),alanine aminotransferase( ALT),aspartate aminotransferase,direct bilirubin,creatinine,detection rate of ANA,and detection rate of SMA( all P < 0. 05). Compared with the acute group,the chronic group had a significantly longer incubation period and a significantly higher proportion of patients with liver cirrhosis or no response to treatment( all P < 0. 05); there was a significant difference between the two groups in the proportion of patients treated with glucocorticoids( χ2= 27. 109,P < 0. 05) or glucocorticoids combined with azathioprine( χ2= 27. 408,P < 0. 05). A total of 16 patients( 11. 6%) in the acute group and 7( 15. 6%) in the chronic group had autoimmune hepatitis-like DILI; 29 patients in the acute group underwent liver pathological examination,among whom2( 6. 9%) had an unknown cause, while 27 patients in the chronic group underwent liver pathological examination, among whom6( 22. 2%) had an unknown cause. ALT( odds ratio [OR]= 0. 997,95% confidence interval [CI]: 0. 985-0. 999,P = 0. 003) and PLT( OR = 0. 997,95% CI: 0. 986-0. 998,P = 0. 013) were independent predictive factors for chronicity of DILI. Conclusion Compared with acute DILI,chronic DILI is more common in female patients and is difficult to diagnose,with a long incubation period,a higher proportion of patients with cholestasis type,and a higher detection rate of autoantibody,and it requires glucocorticoid and immunosuppressive therapy more and tends to have poorer prognosis. ALT and PLT may be independent predictive factors for the chronicity of DILI.

Expression characteristics and significance of three transmembrane transport proteins in liver tissue in bile duct injury type of drug-induced liver injury
Ye LiHong, Zheng HuanWei, Huang XiaoYu, Guo LiJie, Zhang HaiCong, Liu ZhiQuan, Wang ChongKui
2020, 36(7): 1562-1566. DOI: 10.3969/j.issn.1001-5256.2020.07.022
Abstract:

Objective To investigate the expression characteristics and significance of ABCB11( bile salt export pump,BSEP),ABCC2( multidrug resistant protein 2,MRP2),and ABCB4( multidrug resistance associated protein 3,MDR3) in the liver tissue in bile duct injury type of drug-induced liver injury( DILI). Methods Clinical data were collected from 112 patients who had a definite history of medication and were diagnosed with bile duct injury type of DILI based on liver biopsy in The Fifth Hospital of Shijiazhuang from January 2010 to June 2017. The patients were divided into mixed hepatitis group with 40 patients,cholestatic hepatitis group with 40 patients,and simple cholestasis group with 32 patients,and 20 hepatitis B virus carriers without cholestasis were enrolled as control group. Liver biopsy was performed for all subjects to perform immunohistochemical staining of BSEP,MDR3,and MRP2,and the expression characteristics of the three proteins and their association with pathomorphological changes were observed. The expression of these three transport proteins was compared between the three subtypes and its correlation with total bilirubin( TBil),direct bilirubin( DBil),alkaline phosphatase,gamma-glutamyl transpeptidase,and total bile acid( TBA) was analyzed. A one-way analysis of variance was used for comparison of continuous data between groups,and the least significant difference t-test was used for further comparison between two groups; a Pearson correlation analysis was performed to investigate correlation. Results Compared with the control group,the mixed hepatitis group,the cholestatic hepatitis group,and the simple cholestasis group had significant reductions in the expression of BSEP,MDR3,and MRP2 in liver tissue( F =48. 765,45. 424,and 77. 434,all P < 0. 05),and the comparison between any two groups showed that the cholestatic hepatitis group had significantly greater reductions than the mixed hepatitis group and the simple cholestasis group( all P < 0. 05). The degree of hepatocyte swelling and feather-like degeneration due to cholestasis increased with the reduction in the expression of BSEP,MRP2 and MDR3 in the area of cholestasis. In the cholestatic hepatitis group,BSEP was moderately negatively correlated with TBA( r =-0. 640,P = 0. 008),and in the simple cholestasis group,MRP2 was moderately negatively correlated with TBil( r =-0. 597,P = 0. 019) and DBil( r =-0. 643,P = 0. 011). Conclusion There are reductions in the positive expression of BSEP,MDR3,and MRP2 in each subtype of bile duct injury type of DILI,which is one of the important mechanisms of cholestasis in DILI.

Clinical features of liver injury in patients with coronavirus disease 2019: An analysis of 201 cases
Long Dan, Qin LingHui, Gao Shan
2020, 36(7): 1567-1570. DOI: 10.3969/j.issn.1001-5256.2020.07.023
Abstract:

Objective To investigate the features of liver injury in patients with coronavirus disease 2019( COVID-19),and to provide a reference for clinical diagnosis and treatment. Methods Medical records were collected from 201 patients with COVID-19 who were admitted to Xiangyang Central Hospital from January 19 to March 5,2020,and these patients were divided into non-critical( mild/common type) group with 173 patients and critical( severe/critical type) group with 28 patients. The data on alanine aminotransferase( ALT),aspartate aminotransferase( AST),total bilirubin( TBil),direct bilirubin( DBil),and albumin( Alb) were collected. The t-test was used for comparison of normally distributed continuous data between groups,the chi-square test was used for comparison of categorical data between groups,and the Wilcoxon rank-sum test was used for comparison of ranked data between groups. Results Among the 201 patients,37( 18. 4%) had liver injury,with 19 in the critical group and 18 in the non-critical group,and there was a significant difference in the incidence rate of liver injury between the two groups( 67. 9% vs 10. 4%,χ2= 52. 963,P < 0. 05). There were significant differences between the 19 patients with liver injury in the critical group and the 18 patients with liver injury in the non-critical group in the duration of abnormal ALT and/or AST( on admission and during hospitalization)( χ2= 11. 906,P < 0. 05) and the increase in ALT and/or AST( Z =-2. 869,P < 0. 05),and most patients had mild or moderate liver injury. Among the 201 patients,only one patient had elevated bilirubin( TBil < 2 × upper limit of normal,mainly indirect bilirubin) and had non-critical liver injury. The critical group had a significantly lower level of Alb than the non-critical group( t =-8. 002,P < 0. 05). Among the 201 patients,75 had a reduction in Alb,among whom 50( 50/201,24. 9%) had a reduction on admission and 25( 25/201,12. 4%) had a reduction during hospitalization,and there were significant differences in Alb( t =-4. 967,P < 0. 05) and hypoalbuminemia( χ2= 26. 645,P < 0. 05) between the two periods of time. Conclusion Liver injury is relatively common in patients with COVID-19,mainly mild or moderate liver injury. There is a low incidence rate of abnormal bilirubin and a high incidence rate of the reduction in Alb. There are significant differences in the incidence rate and severity of liver injury between the crucial and non-critical patients. Alb level can be used as one of the indicators to evaluate and predict the severity of COVID-19 patients.

Effect of magnesium isoglycyrrhizinate on concanavalin A-induced acute liver failure in mice
Gao YuDi, Tian Yuan, Zhang XiangYing, Zhang XiaoHui, Duan ZhongPing, Ren Feng, Chen Yu
2020, 36(7): 1571-1576. DOI: 10.3969/j.issn.1001-5256.2020.07.024
Abstract:

Objective To investigate the effect of magnesium isoglycyrrhizinate(MgIG) on concanavalin A(ConA)-induced acute liver failure in mice and its mechanism. Methods A total of 60 healthy BALB/C mice were randomly divided into control group with 10 mice,MgIG control group with 10 mice,ConA model group with 20 mice,and MgIG-ConA pretreatment group with 20 mice. The liver and peripheral blood were collected to evaluate survival rate,serum levels of aminotransferases,and degree of liver injury by HE staining of liver tissue; TUNEL fluorescence staining and activity of caspase-3 protein were used to evaluate the apoptosis of hepatocytes; the liquid chip method was used to measure the serum levels of the inflammatory cytokines interleukin-1β(IL-1β) and tumor necrosis factor α(TNFα).A one-way analysis of variance was used for comparison of continuous data between multiple groups,and the least significant difference t-test was used for further comparison between two groups. Results The overall survival rate of mice was 40% in the ConA model group and80% in the MgIG-ConA pretreatment group. The ConA model group had significantly increased serum levels of alanine aminotransferase( ALT) and aspartate aminotransferase( AST) compared with the control group( both P < 0. 01),while the MgIG + ConA pretreatment group had significantly reduced serum levels of ALT and AST compared with the ConA model group( both P < 0. 01). The control group,the MgIG control group,the ConA model group,and the MgIG-ConA pretreatment group had a pathological score of 1. 0 ± 0. 2,1. 2 ± 0. 3,3. 7 ±0. 6,and 2. 3 ± 0. 5,respectively,and there was a significant difference between groups( F = 2. 7,P < 0. 05); the apoptotic cells/100 cells ratio was 0. 2 ± 0. 1,0. 1 ± 0. 1,7. 8 ± 1. 3,and 2. 2 ± 0. 4,respectively,in these four groups,and there was a significant difference between groups( F = 27. 6,P < 0. 001); the activity of caspase-3 protein was 0. 813 ± 0. 022,0. 930 ± 0. 033,1. 347 ± 0. 042,and1. 060 ± 0. 053,respectively,in these four groups,and there was a significant difference between groups( F = 51. 072,P < 0. 001).Compared with the control group,the Con A model group had significant increases in serum levels of IL-1β and TNFα( both P < 0. 05);compared with the Con A model group,the Mg IG + Con A pretreatment group had significant reductions in serum levels of IL-1β and TNFα( both P < 0. 05). Conclusion Mg IG exerts a marked protective effect against Con A-induced acute liver failure in mice and can alleviate liver injury possibly by reducing hepatocyte apoptosis and alleviating liver inflammatory response caused by IL-1β and TNFα.

Effect of aerobic exercise combined with silybin on intestinal mucosal barrier in mice with obstructive jaundice
Peng Lu:Cheng, Shao ZhangFeng, Chen JiaQin, Chen Wei
2020, 36(7): 1577-1583. DOI: 10.3969/j.issn.1001-5256.2020.07.025
Abstract:

Objective To investigate the effect of aerobic exercise combined with silybin in improving intestinal mucosal barrier injury in mice with obstructive jaundice by activating the microRNA-21/TLR4/NF-κB pathway axis in intestinal tissue. Methods Healthy male Kunming mice were selected,and a model of obstructive jaundice was established by the method of hanging the common bile duct using an operating suture line at a right angle. The mice were randomly divided into model group( M group),exercise group( E group),silybin group( S group),and exercise + silybin group( ES group),and a sham-operation group was also established,with 10 mice in each group.After the intervention of aerobic exercise combined with intragastric administration of silybin for 7 weeks,general behavioral observation,ELISA,HE staining of ileal tissue,immunohistochemical staining,measurement of the protein and mRNA expression of intestinal tissue-related factors,and a sequencing analysis of mRNA expression profiles in liver tissue were performed to observe intervention effect. A one-way analysis of variance was used for continuous data,and the least significant difference t-test was used for comparison between groups. A multivariate analysis of variance was used to investigate the interaction effect between aerobic exercise and silybin,and a simple effect analysis was performed. Results The mice in the M group had severe jaundice on the skin of the abdomen and tail,yellow urine,and light gray feces,and laparotomy showed cystic dilatation at the bile duct suspension. Compared with the M group,the E,S,and ES groups had signif-icant reductions in the liver function parameters alanine aminotransferase,aspartate aminotransferase,and total bilirubin( F = 567. 56,1376. 09,and 512. 81,all P < 0. 001),as well as significant reductions in the plasma levels of diamine oxidase( DAO),D-lactic acid,and endotoxin( F = 650. 29,1130. 05,and 396. 04,all P < 0. 001),and there was a synergistic effect between aerobic exercise and silybin in all the above indices except DAO( all P < 0. 05). Microscopic observation showed that the M group had severe damage of the structure of the intestinal mucosa,sparse villi with different heights,a reduction in the depth of intestinal crypts,atrophy and detachment of some glands,and local infiltration of inflammatory cells and muscular atrophy. Compared with the M group,the E and S groups had significant improvements in the above pathological symptoms,and the ES group had the best intervention effect. Compared with the M group,the E,S,and ES groups had significant reductions in the mRNA and protein expression of TLR4,NF-κB,and TNFα( mRNA: F = 104. 69,153. 55,and 262. 38,all P < 0. 01; protein: F = 2683. 83,419. 73,and 572. 41,all P < 0. 01),as well as a significant increase in the expression of microRNA-21( F = 194. 58,P < 0. 01),and there was a synergistic effect between aerobic exercise and silybin in all the above indices except the expression of microRNA-21( all P < 0. 05). According to Illumina high-throughput sequencing for the screening of liver inflammation-related factors and correlation analysis,the differentially expressed factors were mainly enriched in the inflammatory pathways such as NF-κB,TGFβ,TNF,and TLR,which involved tissue cell signal transduction,apoptosis inhibition,immune response,and toxicity,and aerobic exercise and silybin significantly reduced the enrichment of inflammation and immune-related signaling pathways.Conclusion In mice with obstructive jaundice,aerobic exercise or intragastric administration of silybin for 7 weeks can exert a protective effect on intestinal mucosal barrier by upregulating the expression of microRNA-21 in intestinal tissue and inhibiting the TLR4/NF-κB signaling pathway and the release of its downstream inflammatory factors,and aerobic exercise combined with silybin has the optimal effect.

Brief reports
Efficacy of two types of laparoscopic primary suture in treatment of choledocholithiasis: A comparative analysis
Tang ShiChuan, Zheng QinYue, Liu JinHeng, Chen AnPing, Yin SiNeng
2020, 36(7): 1584-1587. DOI: 10.3969/j.issn.1001-5256.2020.07.026
Abstract:
Exchange of clinical experience
Experience in the diagnosis and treatment of acute biliary tract infection during the epidemic of novel coronavirus pneumonia
Yang YaFan, Ge ZhangQing, Yan Jun, Li QuanFu, Zhong YongGang, Zhang Yan, Chen Yang, Xu Xu, Hou GuangBin, Yu Qing
2020, 36(7): 1588-1590. DOI: 10.3969/j.issn.1001-5256.2020.07.027
Abstract:

On January 20,2020,WHO defined the epidemic of novel coronavirus pneumonia as a public health emergency of international concern,and the epidemic attracted worldwide attention. While effectively controlling source of infection,cutting off the route of transmission,and protecting the susceptible population,it is of great importance to reduce the delay in the diagnosis and treatment of patients with acute abdominal disease and ensure normal clinical work. Therefore,with reference to the current diagnosis and treatment protocols and guidelines and the actual situation in Baoding Second Hospital,this article summarizes the experience in outpatient triage,treatment process,operation classification,prevention and control,and ward management for patients with acute biliary tract infection. The analysis shows that the formulation of emergency plans for patients with acute biliary tract infection during the epidemic of novel coronavirus pneumonia can help to differentiate such patients from the patients with novel coronavirus pneumonia and avoid transmission and cross-infection of novel coronavirus during standardized diagnosis and treatment of acute biliary tract infection.

Case reports
Patients with mixed genotype hepatitis C virus infection treated by sofosbuvir/velpatasvir/ribavirin: A case report
Qiu Chen, Jia ShengNan, Zhang Qian, Zhang ChuanHui, Jin ZhenJing, Yang LanLan
2020, 36(7): 1591-1592. DOI: 10.3969/j.issn.1001-5256.2020.07.028
Abstract:
Congenital hepatic fibrosis with retinitis pigmentosa caused by mutations of the TMEM67 gene and CNGB1 gene: A case report
Yang Fan, Wang YiRou, Yu XiaoDan, Ma Xiong, Wang XiuMin
2020, 36(7): 1593-1595. DOI: 10.3969/j.issn.1001-5256.2020.07.029
Abstract:
A case of complete esophageal obstruction caused by esophageal variceal ligation
Zhang WeiGuang, Chen WanWei, Yang HaoYi, Xu LiangBi, Yang Ting
2020, 36(7): 1596-1597. DOI: 10.3969/j.issn.1001-5256.2020.07.030
Abstract:
Severe alcoholic hepatitis with leukemoid reaction: A report of 3 cases
Yao QiuYan, Shi RongJie
2020, 36(7): 1598-1600. DOI: 10.3969/j.issn.1001-5256.2020.07.031
Abstract:
Progressive familial intrahepatic cholestasis type 3: A report of two cases in one pedigree
Li AiQin, Dong Yi, Xu ZhiQiang, Wang FuChuan, Wang LiMin, Yan JianGuo, Cao LiLi, Wang Pu, Zhang Min
2020, 36(7): 1601-1604. DOI: 10.3969/j.issn.1001-5256.2020.07.032
Abstract:
Invasive primary hepatic epithelioid hemangioendothelioma: A case report
Zhang LiYuan, Wu KunLiang, Li Jun, Du YongGuo
2020, 36(7): 1605-1607. DOI: 10.3969/j.issn.1001-5256.2020.07.033
Abstract:
A case of abdominal foreign body misdiagnosed as peritoneal metastasis of liver cancer
Fan YeHui, Chai YaTing, Meng ShanShan, Wang GuangYi, Wang XiaoLei
2020, 36(7): 1610-1611. DOI: 10.3969/j.issn.1001-5256.2020.07.034
Abstract:
Reviews
Advances in the diagnosis and treatment of HBeAg-negative chronic hepatitis B
Chen HuaXian, Wei Jia
2020, 36(7): 1612-1614. DOI: 10.3969/j.issn.1001-5256.2020.07.035
Abstract:

Chronic hepatitis B( CHB) is one of the most common chronic infectious diseases in China,and the prevalence rate of HBeAg-negative CHB has been increasing year by year,causing serious harm to the security of public health in China. With reference to the pathogenesis,diagnosis,and treatment of HBeAg-negative CHB,this article reviews the clinical research advances in recent years and summarizes the new advances in the diagnosis and treatment of HBeAg-negative CHB.

Pathogenesis and clinical prevention and treatment of osteoporosis in patients with hepatitis B
Han YiFan, Xu XiaoYuan
2020, 36(7): 1615-1618. DOI: 10.3969/j.issn.1001-5256.2020.07.036
Abstract:

With the improvement in clinical treatment and the increase in life expectancy,the incidence rate of osteoporosis is gradually increasing in patients with hepatitis B. However,the specific mechanism of different stages of hepatitis B on osteoporosis is still complex and remains unclear,and there are few studies on the prevention and treatment of osteoporosis in patients with hepatitis B. This article reviews the pathogenesis and clinical prevention and treatment of osteoporosis in patients with hepatitis B,in order to provide better guidance for clinical management and treatment.

Pathogenic mechanism of liver injury caused by coronavirus disease 2019 and protective strategies for patients with viral hepatitis cirrhosis
Lei SiYi, Peng Hong, Luo XinHua
2020, 36(7): 1619-1622. DOI: 10.3969/j.issn.1001-5256.2020.07.037
Abstract:

Coronavirus disease 2019( COVID-19) has spread to many countries in the world,and some patients show liver injury during the epidemic of COVID-19. In order to improve the awareness of COVID-19 among patients with viral hepatitis cirrhosis and strengthen patients' self-protection and disease management,this article discusses the pathogenic mechanism of liver injury caused by COVID-19 and reasonable epidemic prevention,standardized medical treatment,and scientific medication for such patients and gives related recommendations,so as to ensure the routine management of viral hepatitis and reduce the risk of infection in such population.

Risk factors for childhood nonalcoholic fatty liver disease and related prevention and management strategies
Yao ChengZi, Liu ZiZhen, Feng Gong, He Na, Mi Man
2020, 36(7): 1623-1626. DOI: 10.3969/j.issn.1001-5256.2020.07.038
Abstract:

Childhood nonalcoholic fatty liver disease( NAFLD) is one of the most common cause of chronic liver diseases in children and adolescents; its unique histopathological and clinical features may lead to its progression to liver fibrosis,liver cirrhosis,and liver cancer,and compared with adult NAFLD,it is more likely to cause other diseases and increase mortality rate. Therefore,early identification of risk factors for childhood NAFLD,effective screening of high-risk population,active prevention,and early diagnosis and treatment are key to effective clinical management of this disease. This article elaborates on the risk factors,screening methods,and preventive healthcare measures for childhood NAFLD,in order to standardize the comprehensive management of NAFLD,reduce the prevalence rate of NAFLD,delay its progression,and alleviate the economic and public health burden brought by the disease.

Association between nonalcoholic fatty liver disease and gut microbiota based on the theory of gut-liver axis
Hui DengCheng, Sun MingYu
2020, 36(7): 1627-1630. DOI: 10.3969/j.issn.1001-5256.2020.07.039
Abstract:

Nonalcoholic fatty liver disease( NAFLD) has become the most important chronic liver disease and is recognized as the hepatic manifestation of metabolic syndrome,which may progress to liver fibrosis,liver cirrhosis,and even hepatocellular carcinoma in the advanced stage. Gut microbiota,as important symbiotic organisms in the human body,affects metabolic function and may be closely associated with NAFLD,and the theory of gut-liver axis provides a theoretical basis for understanding that intestinal dysbacteriosis may cause liver pathological changes. This article explores the association between NAFLD and gut microbiota,so as to lay a theoretical foundation for the future research on the therapy for NAFLD targeting gut microbiota.

Role of the OPG/RANKL/RANK signaling pathway in the progression of nonalcoholic fatty liver disease
Xiang Zhao, Yang JinHui
2020, 36(7): 1631-1633. DOI: 10.3969/j.issn.1001-5256.2020.07.040
Abstract:

Nonalcoholic fatty liver disease( NAFLD) has now become the most common liver disease around the world,and there is an urgent need for better diagnosis and treatment of NAFLD. The osteoprotegerin( OPG)/receptor activator of nuclear factor-kappa B ligand( RANKL)/receptor activator of nuclear factor-kappa B( RANK) signaling pathway is an important signaling pathway involved in the balance of bone metabolism. This article introduces the OPG,RANKL,RANK,and OPG/RANKL/RANK systems and elaborates on the current research on the role of the OPG/RANKL/RANK signaling pathway in regulating the production of inflammatory factors and promoting the progression of NAFLD by activating NF-κB. It is pointed out that the OPG/RANKL/RANK system may be used as a potential target for the treatment of NAFLD.

Risk factors for hepatitis B virus-related hepatocellular carcinoma
Ren DanDan, Liu Na, Zhou LuLu, Zhang Nan, Li ChunXia, Dong Bing, Xu GuangHua
2020, 36(7): 1634-1638. DOI: 10.3969/j.issn.1001-5256.2020.07.041
Abstract:

At present,hepatitis B virus( HBV) infection is recognized as an important risk factor for hepatocellular carcinoma( HCC) in the world; however,during the development and progression of hepatitis B,liver cirrhosis,and liver cancer,other factors may promote the development of HCC independently or synergistically with HBV,such as sex,age,family history,alanine aminotransferase/aspartate aminotransferase,smoking and drinking history,metabolic syndrome,and HCV or HIV infection. This article reviews the research advances in the risk factors associated with HCC.

Research advances in hepatocellular carcinoma-related sarcopenia
Shen SuYa, Huang JianZhao, Liu Yan, Liu JiangWei, Zhang XuYang, Ye KunQi, Pan NingBo
2020, 36(7): 1639-1642. DOI: 10.3969/j.issn.1001-5256.2020.07.042
Abstract:

Hepatocellular carcinoma( HCC) is a common malignant tumor and patients with HCC often have liver cirrhosis,with an extremely high 5-year recurrence rate and poor prognosis even after curative treatment. In recent years,sarcopenia has attracted more and more attention as a poor prognostic factor for various malignant tumors; however,there is still a lack of studies on the association between skeletal muscle index and prognosis of HCC in China. Evidence in foreign countries has shown that sarcopenia may be an a negative prognostic factor for HCC patients. This article reviews the etiology and possible pathogenesis of HCC-related sarcopenia and related intervention measures including nutritional supplementation,appropriate physical exercise,and medication,in order to provide a reference for related studies in China.

Role of polymeric immunoglobulin receptor in the metastasis,growth,diagnosis,and treatment of hepatocellular carcinoma
Zhang Yuan, Chen XiaoRong, Yang ZongGuo
2020, 36(7): 1643-1645. DOI: 10.3969/j.issn.1001-5256.2020.07.043
Abstract:

Chronic inflammation of the liver is a risk factor that promotes the progression of hepatocellular carcinoma,and in the presence of viral infection,enhanced Fc receptor signal will further aggravate inflammatory response and participate in the process of canceration. Polymeric immunoglobulin receptor( pIgR) not only plays a critical role in first-line anti-infection immunity,but also promotes the metastasis and growth of early-stage hepatocellular carcinoma. Identifying pIgR as a predictive index for metastatic potential in patients with early-stage liver cancer can help to promote the stratification and treatment decisions for such patients,which has a positive significance in improving patient prognosis. Targeted inhibition of the pIgR/Yes signal cascade as a potential treatment option may provide more treatment options for controlling tumor size to allow resection or transplantation.

A new treatment strategy for primary liver cancer based on the theory of the oral-gut-liver axis
Zhou Cheng, Zhang JiaMing, Guo Li, Si HaiLong, Xiao HaiJuan, Yang Lin
2020, 36(7): 1646-1649. DOI: 10.3969/j.issn.1001-5256.2020.07.044
Abstract:
Primary liver cancer has various potential causes and insidious onset,and its progression is affected by many factors. Immunotherapy and targeted drug therapy have been used as non-radical treatment methods for primary liver cancer,but they cannot achieve a satisfactory effect and may lead to drug resistance. In recent years,the wide application of 16 s high-throughput sequencing and the in-depth studies of microbiology have revealed the key role of microorganisms in the development and progression of liver cancer. The association of the liver with oral and intestinal flora is gradually clarified,and the regulation of oral and intestinal flora has brought new treatment methods for the disease. This article reviews the microbial theory of the oral-gut-liver axis and its application and development in the treatment of primary liver cancer.
Advances in the role of microRNA in the intervention of malignant transformation of precancerous lesions of the liver by regulating the activation of hepatic stellate cells
Wu Jie, Li JingTao, Wei HaiLiang, Yan ShuGuang, Fan Yu, Guo YingJun, Chang ZhanJie
2020, 36(7): 1650-1654. DOI: 10.3969/j.issn.1001-5256.2020.07.045
Abstract:

The development and progression of liver cancer have the stages of hepatitis,liver cirrhosis,precancerous lesion,and liver cancer,among which the malignant transformation of precancerous lesions of liver cancer is closely associated with the activation of hepatic stellate cells( HSC). By describing the activation of HSC,the generation of precancerous cells of liver cancer,the formation of inflammatory fibrotic microenvironment,and the association between HSC activation and precancerous lesion,this article points out that microRNAs can affect the malignant transformation of precancerous lesion of liver cancer by regulating the expression of related target genes and HSC activation,and the research in this field is expected to provide new ideas and targets for the prevention and treatment of liver cancer.

Mechanism of action of regulatory B cells in the development and progression of autoimmune hepatitis
Tong Cong, Xiang XiaoXing
2020, 36(7): 1655-1657. DOI: 10.3969/j.issn.1001-5256.2020.07.046
Abstract:
Autoimmune hepatitis is a type of autoimmune disease and has known pathogenesis at present,which is believed to be associated with immune imbalance in the body. In inflammatory diseases,regulatory B cells( Bregs) inhibits the differentiation of CD4+T lymphocytes into T helper 1 cells and T helper 17 cells by secreting interleukin-10( IL-10) to inhibit inflammatory response. Patients with autoimmune hepatitis have reductions in the level of IL-10 in peripheral blood and the number and function of Bregs,which leads to the fact that Bregs cannot effectively inhibit inflammatory response,suggesting that Bregs play a certain role in the pathogenesis of autoimmune hepatitis.This article reviews the mechanism of action of Breg subsets in autoimmune hepatitis.
Predictive factors and interventions for prolonged mechanical ventilation after liver transplantation
Wang Han, Zuo XiangRong, Cao Quan
2020, 36(7): 1658-1662. DOI: 10.3969/j.issn.1001-5256.2020.07.047
Abstract:
Despite the great improvements in the techniques and perioperative management of liver transplantation in recent years,there are still several perioperative complications that may lead to the poor prognosis of recipients. Prolonged mechanical ventilation( PMV) is a common complication in the early stage after surgery and may result in a high incidence rate of postoperative complications,prolonged length of stay in the intensive care unit and hospital stay,and an increase in mortality rate. In recent years,many studies have reported PMV after liver transplantation,but no summarization and statistical analysis have been performed and there are still no effective measures to prevent PMV after liver transplantation. This article summarizes the influencing factors and interventions for PMV after liver transplantation,in order to provide valuable information for reducing the duration of mechanical ventilation after liver transplantation and improving the prognosis of liver transplantation recipients.
PINK1/Parkin-mediated mitophagy and its mechanism of action in the development and progression of liver diseases
Zhang Hao, Zhang Yue, Zhao WenWu, Zhang JingGe
2020, 36(7): 1663-1665. DOI: 10.3969/j.issn.1001-5256.2020.07.048
Abstract:

Mitophagy is the process of selective clearance of damaged mitochondria by autophagy. There are several regulatory mechanisms for mitophagy,and the PINK1/Parkin pathway is considered the main pathway for mitophagy. Recent studies have shown that PINK1/Parkin-mediated mitophagy plays an important role in the pathogenesis of various diseases including Parkinson's disease. This article introduces the mechanism of PINK1/Parkin-mediated mitophagy and its role in various liver diseases including nonalcoholic fatty liver disease,liver fibrosis,and hepatocellular carcinoma,in order to provide new clues and ideas for the treatment of diseases.

Mechanism of action of microRNA-27a in the development and progression of liver diseases
Luo Xin, Xu MingYi
2020, 36(7): 1666-1668. DOI: 10.3969/j.issn.1001-5256.2020.07.049
Abstract:

microRNAs( miRNAs) are low-molecular-weight non-coding RNAs that regulate various physiological and pathological functions through the regulation of gene expression at the post-transcriptional level. More and more evidence has shown that microRNA-27 a( miRNA-27 a) plays a role in the development and pathogenesis of liver diseases. By reviewing and updating related studies,this article introduces the research advances in the role of miRNA-27 a in various liver diseases including fatty liver disease,hepatitis,hepatic fibrosis,and liver cancer and analyzes the role of miRNA-27 a in liver regeneration and its potential as a biomarker,so as to provide a reference for future studies and more possibilities for new treatment ideas for chronic hepatic diseases.

Early diagnosis of acute pancreatitis in pregnancy
Zhang TingTing, Liu RuiXia, Yin ChengHong
2020, 36(7): 1669-1672. DOI: 10.3969/j.issn.1001-5256.2020.07.050
Abstract:
Acute pancreatitis in pregnancy is one of the rare and serious complications in pregnancy and has sudden onset,rapid disease progression,and difficulty in diagnosis,and thus it greatly threatens the health of mother and infant. Accurate judgement of the etiology of acute pancreatitis in pregnancy and confirmed diagnosis as early as possible are the key to successful clinical treatment. This article summarizes the recent advances in the early diagnosis of this disease from the aspects of etiology of acute pancreatitis in pregnancy,methods for early diagnosis and examination,and differential diagnosis of this disease from other diseases.